ARID1A and neoplasm: Patients with tumours showing lower ARID1A and PTEN levels had a poorer survival compared to other patient groups combined (ARID1A low PTEN low median survival 31 months vs all other groups median survival 57 months *p = 0.0303) (Fig. 4e).